Vitti Long Haul advances research for Long COVID and pulmonary fibrosis through innovative clinical trials. Our work focuses on mesenchymal stem cells, exosomes, and regenerative medicine.

Vitti Long Haul is dedicated to advancing innovative research for Long COVID and pulmonary fibrosis through regenerative medicine. Our work focuses on mesenchymal stem cells, exosomes, and advanced biomaterials to support ongoing clinical trials and future treatment options. We are committed to scientific innovation, patient-focused research, and improving outcomes for individuals affected by long-term post-COVID conditions.